| Prevalence (%) | Number of IGT (%) | OR (95% CI) | AROC (95% CI) | AR % | PAR % |
---|---|---|---|---|---|---|
MS-NCEP | 309 (33.3) | 129 (41.8) | 3.16 (2.26-4.42) | 63.4 (60.3-66.5) | 64.0 | 37.2 |
MS-IDF | 278 (30.0) | 132 (42.1) | 2.84 (2.03-3.97) | 63.0 (60.0 -66.0) | 61.6 | 32.5 |
Central obesity | 489 (52.7) | 158 (32.3) | 2.06 (1.46-2.91) | 58.9 (56.2-61.5) | 54.9 | 39.1 |
Hyperglycemia | 279 (30.1) | 118 (42.3) | 2.79 (1.99-3.91) | 66.9 (61.5-72.3) | 61.3 | 32.6 |
High TG | 293 (31.6) | 96 (32.8) | 1.95 (1.39-2.74) | 56.5 (53.4-59.6) | 39.4 | 17.1 |
Low HDL-C | 301 (32.4) | 91 (30.2) | 1.65 (1.19-2.30) | 54.7 (51.6-57.7) | 30.9 | 12.7 |
High BP | 415 (44.7) | 141 (34.0) | 1.61 (1.13-2.30) | 59.1 (56.3-62.9) | 53.5 | 34.0 |